The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study
- PMID: 31470068
- PMCID: PMC6921701
- DOI: 10.1016/j.jhep.2019.08.018
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study
Abstract
Background & aims: Cancer is a major cause of death in patients with non-alcoholic fatty liver disease (NAFLD). Obesity is a risk factor for cancers; however, the role of NAFLD in this association is unknown. We investigated the effect of NAFLD versus obesity on incident cancers.
Methods: We identified all incident cases of NAFLD in a US population between 1997-2016. Individuals with NAFLD were matched by age and sex to referent individuals from the same population (1:3) on the index diagnosis date. We ascertained the incidence of cancer after index date until death, loss to follow-up or study end. NAFLD and cancer were defined using a code-based algorithm with high validity and tested by medical record review. The association between NAFLD or obesity and cancer risk was examined using Poisson regression.
Results: A total of 4,722 individuals with NAFLD (median age 54, 46% male) and 14,441 age- and sex-matched referent individuals were followed for a median of 8 (range 1-21) years, during which 2,224 incident cancers occurred. NAFLD was associated with 90% higher risk of malignancy: incidence rate ratio (IRR) = 1.9 (95% CI 1.3-2.7). The highest risk increase was noted in liver cancer, IRR = 2.8 (95% CI 1.6-5.1), followed by uterine IRR = 2.3 (95% CI 1.4-4.1), stomach IRR = 2.3 (95% CI 1.3-4.1), pancreas IRR = 2.0 (95% CI 1.2-3.3) and colon cancer IRR = 1.8 (95% CI 1.1-2.8). In reference to non-obese controls, NAFLD was associated with a higher risk of incident cancers (IRR = 2.0, 95% CI 1.5-2.9), while obesity alone was not (IRR = 1.0, 95% CI 0.8-1.4).
Conclusions: NAFLD was associated with increased cancer risk, particularity of gastrointestinal types. In the absence of NAFLD, the association between obesity and cancer risk is small, suggesting that NAFLD may be a mediator of the obesity-cancer association.
Lay summary: We studied the incidence of malignancies in a community cohort of adults with non-alcoholic fatty liver disease (NAFLD) in reference to age- and sex-matched adults without NAFLD. After 21 years of longitudinal follow-up, NAFLD was associated with a nearly 2-fold increase in the risk of developing cancers, predominantly of the liver, gastrointestinal tract and uterus. The association with increased cancer risk was stronger in NAFLD than obesity.
Keywords: Epidemiology; NAFLD; NASH; Natural history; Outcomes.
Copyright © 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Figures
Comment in
-
Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver?J Hepatol. 2019 Dec;71(6):1073-1075. doi: 10.1016/j.jhep.2019.09.020. Epub 2019 Oct 3. J Hepatol. 2019. PMID: 31586595 No abstract available.
-
The "obese liver" and gastrointestinal cancer risk.Transl Gastroenterol Hepatol. 2020 Jul 5;5:44. doi: 10.21037/tgh.2019.12.07. eCollection 2020. Transl Gastroenterol Hepatol. 2020. PMID: 32632395 Free PMC article. No abstract available.
-
Metabolic associated fatty liver disease and cancer risk: causal role or epiphenomenon?Hepatobiliary Surg Nutr. 2020 Dec;9(6):774-776. doi: 10.21037/hbsn.2020.03.05. Hepatobiliary Surg Nutr. 2020. PMID: 33299832 Free PMC article. No abstract available.
Similar articles
-
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.BMJ. 2019 Oct 8;367:l5367. doi: 10.1136/bmj.l5367. BMJ. 2019. PMID: 31594780 Free PMC article.
-
Bariatric Surgery Reduces Cancer Risk in Adults With Nonalcoholic Fatty Liver Disease and Severe Obesity.Gastroenterology. 2021 Jul;161(1):171-184.e10. doi: 10.1053/j.gastro.2021.03.021. Epub 2021 Mar 18. Gastroenterology. 2021. PMID: 33744305
-
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.Gut. 2022 Apr;71(4):778-788. doi: 10.1136/gutjnl-2021-324191. Epub 2021 Mar 8. Gut. 2022. PMID: 33685968
-
Gastrointestinal cancers in lean individuals with non-alcoholic fatty liver disease: A systematic review and meta-analysis.Liver Int. 2024 Jan;44(1):6-14. doi: 10.1111/liv.15763. Epub 2023 Oct 13. Liver Int. 2024. PMID: 37833849 Review.
-
Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis.Eur J Cancer. 2022 Sep;173:250-262. doi: 10.1016/j.ejca.2022.06.051. Epub 2022 Aug 6. Eur J Cancer. 2022. PMID: 35944373 Review.
Cited by
-
The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.JHEP Rep. 2022 Jun 15;4(9):100525. doi: 10.1016/j.jhepr.2022.100525. eCollection 2022 Sep. JHEP Rep. 2022. PMID: 36039144 Free PMC article.
-
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.Gut. 2021 Jul;70(7):1375-1382. doi: 10.1136/gutjnl-2020-322786. Epub 2020 Oct 9. Gut. 2021. PMID: 33037056 Free PMC article.
-
Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease.Front Endocrinol (Lausanne). 2021 Dec 7;12:760981. doi: 10.3389/fendo.2021.760981. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34950103 Free PMC article.
-
Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.J Hepatol. 2021 Nov;75(5):1034-1041. doi: 10.1016/j.jhep.2021.06.034. Epub 2021 Jul 3. J Hepatol. 2021. PMID: 34224779 Free PMC article.
-
Unveiling the cancer risk nexus of the steatotic liver.Trends Endocrinol Metab. 2024 Aug;35(8):708-719. doi: 10.1016/j.tem.2024.02.017. Epub 2024 Mar 25. Trends Endocrinol Metab. 2024. PMID: 38531699 Review.
References
-
- Hastings KG, Boothroyd DB, Kapphahn K, Hu J, Rehkopf DH, Cullen MR, Palaniappan L. Socioeconomic Differences in the Epidemiologic Transition From Heart Disease to Cancer as the Leading Cause of Death in the United States, 2003 to 2015: An Observational Study. Ann Intern Med 2018;169:836–844. - PubMed
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–2917. - PubMed
-
- Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–578. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
